This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The contract, valued at $1,134,584.52, is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The contract is for the acquisition of medical countermeasures for pandemic influenza preparedness and response, including the production, formulation, and storage of influenza antigens for national stockpiles. Seqirus, a leading provider of such medical countermeasures to the U.S. government, operates a manufacturing facility in Holly Springs, North Carolina. This contract award did not utilize a set-aside designation, reflecting Seqirus' status as an established contractor in this specialized field.